

Introduction: The aim of this study was to investigate lipoprotein particle distributions and the likelihood of achieving cholesterol homeostasis in the remission phase of nephrotic syndrome (NS) in paediatric patients. We hypothesized that lipoprotein particle distributions moved toward less atherogenic profile and that cholesterol homeostasis was achieved. Materials and methods: Thirty-three children, 2 to 9 years old with NS were recruited. Blood sampling took place both in the acute phase and during remission. Serum low-density lipoprotein particles (LDL) and high-density lipoprotein particles (HDL) were separated using non-denaturing polyacrylamide gradient gel (3-31%) electrophoresis. Serum non-cholesterols sterols (NCSs), desmosterol, lathosterol, 7-dehydrocholesterol (7-DHC), campesterol and β-sitosterol were measured by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Results: All patients had desirable serum HDL cholesterol concentrations during remission. The dominant lipoprotein diameters and LDL subclass distribution did not change significantly during follow-up. In contrast, HDL lipoprotein particle distribution shifted towards larger particles. The absolute concentration of desmosterol was significantly lower during remission (P = 0.023). β-sitosterol concentration markedly increased during remission (P = 0.005). Desmosterol/β-sitosterol (P < 0.001) and 7-DHC/β-sitosterol (P = 0.005) ratios significantly declined during disease remission. Conclusions: Favourable changes in the serum lipid profiles, HDL particle subclass distribution and cholesterol metabolism in paediatric patients with NS during remission took place. For the first time, we found that cholesterol homeostasis changed in favour of increased cholesterol absorption during disease remission. Nevertheless, complete cholesterol homeostasis was not achieved during disease remission. © by Croatian Society of Medical Biochemistry and Laboratory Medicine.
| EMTREE drug terms: | alanine aminotransferaseaspartate aminotransferasecholesterolcreatinineglucocorticoidhigh density lipoproteinhigh density lipoprotein cholesterollipoproteinlow density lipoproteinlow density lipoprotein cholesterolprednisolonedesmosterolhigh density lipoprotein cholesterollipoprotein |
|---|---|
| EMTREE medical terms: | Articleatherosclerosisblood samplingbody masschildclinical articlecreatinine blood leveldiastolic blood pressurefemalefollow uphigh performance liquid chromatographyhomeostasishumanhuman tissueliquid chromatography-mass spectrometrymalemass spectrometrynephrotic syndromeparticle sizepreschool childprotein blood levelprotein denaturationprotein homeostasisremissionschool childsystolic blood pressuretandem mass spectrometry |
| MeSH: | ChildChild, PreschoolCholesterol, HDLDesmosterolHumansLipoproteinsNephrotic SyndromeTandem Mass Spectrometry |
alanine aminotransferase, 9000-86-6, 9014-30-6; aspartate aminotransferase, 9000-97-9; cholesterol, 57-88-5; creatinine, 19230-81-0, 60-27-5; prednisolone, 50-24-8; desmosterol, 313-04-2;
Cholesterol, HDL; Desmosterol; Lipoproteins
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| 200161 | ||
| 451-03-68/2022-14/200161 |
This research was funded by the Ministry of Education, Science and Technological Development, Republic of Serbia through Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-68/2022-14/200161.
Stefanović, A.; Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia;
© Copyright 2022 Elsevier B.V., All rights reserved.